Boston Scientific Corporation vs Estee Lauder Companies Inc — how do they compare? Boston Scientific Corporation trades at $51.07 (market cap $74.19B), while Estee Lauder Companies Inc trades at $88.01 (market cap $31.76B). The key difference: Boston Scientific Corporation is far larger — about 2.3× Estee Lauder Companies Inc's market cap, and Estee Lauder Companies Inc pays a 1.59% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | EL | |
|---|---|---|
Market Cap | $74.19B | $31.76B |
Sector | Health | Consumer Staples |
52-Week High | $108.14 | $119.61 |
52-Week Low | $42.63 | $67.23 |
Enterprise Value | $86.27B | $37.93B |
Dividend Yield | — | 1.59% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →